Suzhou Basecare Medical Corp. Ltd. Class H (2170) Stock Statistics & Valuation Metrics

Suzhou Basecare Medical Corp. Ltd. Class H has a market cap or net worth of HK$771.34M. The enterprise value is HK$441.90M.

Suzhou Basecare Medical Corp. Ltd. Class H has 82,713,840 shares outstanding. The number of shares has decreased by -2.65% in one year.

Suzhou Basecare Medical Corp. Ltd. Class H’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -15.16%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Suzhou Basecare Medical Corp. Ltd. Class H had revenue of 299.11M and earned -237.03M in profits. Earnings per share was -0.87.

In the last 12 months, operating cash flow was -122.24M and capital expenditures -55.40M, giving a free cash flow of -177.64M billion.

Suzhou Basecare Medical Corp. Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―

Suzhou Basecare Medical Corp. Ltd. Class H upcoming earnings date is Sep 1, 2025, TBA (Confirmed).

Suzhou Basecare Medical Corp. Ltd. Class H as a current ratio of 5.03, with Debt / Equity ratio of 28.73%

In the past 12 months, Suzhou Basecare Medical Corp. Ltd. Class H has paid -3.13M in taxes.

Suzhou Basecare Medical Corp. Ltd. Class H EV to EBITDA ratio is -1.81, with an EV/FCF ratio of 0.00.

Suzhou Basecare Medical Corp. Ltd. Class H has HK$684.63M in cash and marketable securities with ¥328.42M in debt, giving a net cash position of -HK$356.21M billion.

Gross margin is 45.54%, with operating margin of -77.22%, and net profit margin of -79.25%.

The average price target for Suzhou Basecare Medical Corp. Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―